ELCC 2017 | Increasing treatment options for NSCLC
David Gandara
David Gandara, MD from the University of California, Davis, CA discusses the recent change in the treatment landscape of advanced non-small cell lung cancer (NSCLC) and what we can expect in the future. There have been great advances in the treatment of advanced NSCLC, however an increase in the number of treatment options brings rise to new challenges and questions that need to be dealt with. This interview was recorded at the annual meeting of the European Lung Cancer Conference (ELCC) 2017, Geneva, Switzerland.
Similar topics
Related videos

Accelerate, Coordinate, Evaluate (ACE) cancer care: the CRUK programme streamlining the care pathway
Sara Hiom

Lung cancer screening in the UK: CRUK, UK NSC, Public Health England & NHS England
Sara Hiom

The Recovery Package in lung cancer
Josie Roberts

Single-port VATS for NSCLC: outcomes related to smoking status
John Edwards

Psychological impact of lung cancer screening
Mamta Ruparel
et al.
More from David Gandara